US BANCORP \DE\ - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$2,000
-83.3%
336
-73.9%
0.00%
Q4 2021$12,000
-47.8%
1,2860.0%0.00%
Q3 2021$23,000
-28.1%
1,286
-3.3%
0.00%
Q2 2021$32,000
-5.9%
1,330
+3.4%
0.00%
Q1 2021$34,000
+240.0%
1,2860.0%0.00%
Q4 2020$10,000
+900.0%
1,286
+533.5%
0.00%
Q2 2020$1,0000.0%203
-22.5%
0.00%
Q1 2020$1,0002620.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders